141
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluations

Sustained release oral fampridine in the treatment of multiple sclerosis

, MD
Pages 2025-2035 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Keith C Hayes. (2011) Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatric Disease and Treatment 7, pages 229-239.
Read now
Nancy L Kuntz, Dorothee Chabas, Bianca Weinstock-Guttman, Tanuja Chitnis, E Ann Yeh, Lauren Krupp, Jayne Ness, Moses Rodriguez & Emmanuelle Waubant. (2010) Treatment of multiple sclerosis in children and adolescents. Expert Opinion on Pharmacotherapy 11:4, pages 505-520.
Read now

Articles from other publishers (8)

L. Brambilla, D. Rossi Sebastiano, D. Aquino, V. Torri Clerici, G. Brenna, M. Moscatelli, R. Frangiamore, A.M. Giovannetti, C. Antozzi, R. Mantegazza, S. Franceschetti, M.G. Bruzzone, A. Erbetta & P. Confalonieri. (2016) Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness. Journal of the Neurological Sciences 368, pages 402-407.
Crossref
Henrik Boye Jensen, Mads Ravnborg, Ulrik Dalgas & Egon Stenager. (2013) 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Therapeutic Advances in Neurological Disorders 7:2, pages 97-113.
Crossref
Alexander Velumian & Marina Samoilova. 2014. White Matter Injury in Stroke and CNS Disease. White Matter Injury in Stroke and CNS Disease 3 38 .
Babak Jalilian, Halldór Einarsson & Thomas Vorup-Jensen. (2012) Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?. International Journal of Molecular Sciences 13:12, pages 14579-14605.
Crossref
Carmen Espejo & Xavier Montalban. (2012) Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation. Clinical Immunology 142:1, pages 84-92.
Crossref
Alexander G. Rabchevsky, Samir P. Patel & Joe E. Springer. (2011) Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?. Pharmacology & Therapeutics 132:1, pages 15-29.
Crossref
Tanuja Chitnis, Lauren Krupp, Ann Yeh, Jennifer Rubin, Nancy Kuntz, Jonathan B. Strober, Dorothee Chabas, Bianca Weinstock-Guttmann, Jayne Ness, Moses Rodriguez & Emmanuelle Waubant. (2011) Pediatric Multiple Sclerosis. Neurologic Clinics 29:2, pages 481-505.
Crossref
Junger Tang & Moses Rodriguez. (2010) Dalfampridine for the treatment of ambulatory impairment in multiple sclerosis. Future Neurology 5:5, pages 637-643.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.